KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
84 hedge funds and large institutions have $472M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $493M → $472M (-$20.1M)
Holders
84
Holding in Top 10
6
Calls
$569K
Puts
–
Top Buyers
| 1 | +$14.5M | |
| 2 | +$3.16M | |
| 3 | +$2.83M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$1.54M |
| 5 |
Millennium Management
New York
|
+$943K |
Top Sellers
| 1 | -$6.45M | |
| 2 | -$4.14M | |
| 3 | -$3.88M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.75M |
| 5 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$1.3M |